nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—HTR2C—type 2 diabetes mellitus	0.258	0.667	CbGaD
Prochlorperazine—CYP3A4—type 2 diabetes mellitus	0.129	0.333	CbGaD
Prochlorperazine—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0737	0.188	CbGbCtD
Prochlorperazine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.052	0.132	CbGbCtD
Prochlorperazine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0432	0.11	CbGbCtD
Prochlorperazine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0227	0.0577	CbGbCtD
Prochlorperazine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0224	0.0569	CbGbCtD
Prochlorperazine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0209	0.0533	CbGbCtD
Prochlorperazine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.02	0.0508	CbGbCtD
Prochlorperazine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0182	0.0464	CbGbCtD
Prochlorperazine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0172	0.0437	CbGbCtD
Prochlorperazine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0165	0.0419	CbGbCtD
Prochlorperazine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.016	0.0406	CbGbCtD
Prochlorperazine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0144	0.0367	CbGbCtD
Prochlorperazine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0109	0.0278	CbGbCtD
Prochlorperazine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0105	0.0267	CbGbCtD
Prochlorperazine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0105	0.0267	CbGbCtD
Prochlorperazine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00991	0.0252	CbGbCtD
Prochlorperazine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00738	0.0188	CbGbCtD
Prochlorperazine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00675	0.0172	CbGbCtD
Prochlorperazine—Infection—Bromocriptine—type 2 diabetes mellitus	0.000184	0.00118	CcSEcCtD
Prochlorperazine—Jaundice—Irbesartan—type 2 diabetes mellitus	0.000184	0.00117	CcSEcCtD
Prochlorperazine—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000184	0.00117	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Losartan—type 2 diabetes mellitus	0.000183	0.00117	CcSEcCtD
Prochlorperazine—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000183	0.00117	CcSEcCtD
Prochlorperazine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000182	0.00116	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000182	0.00116	CcSEcCtD
Prochlorperazine—Nervousness—Gliclazide—type 2 diabetes mellitus	0.000181	0.00116	CcSEcCtD
Prochlorperazine—Weight increased—Losartan—type 2 diabetes mellitus	0.000181	0.00116	CcSEcCtD
Prochlorperazine—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.00018	0.00115	CcSEcCtD
Prochlorperazine—Convulsion—Glyburide—type 2 diabetes mellitus	0.00018	0.00115	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.00018	0.00115	CcSEcCtD
Prochlorperazine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000178	0.00114	CcSEcCtD
Prochlorperazine—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.000177	0.00113	CcSEcCtD
Prochlorperazine—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000176	0.00112	CcSEcCtD
Prochlorperazine—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000175	0.00112	CcSEcCtD
Prochlorperazine—Urticaria—Glipizide—type 2 diabetes mellitus	0.000175	0.00112	CcSEcCtD
Prochlorperazine—Tremor—Gliclazide—type 2 diabetes mellitus	0.000175	0.00112	CcSEcCtD
Prochlorperazine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000174	0.00111	CcSEcCtD
Prochlorperazine—Jaundice—Losartan—type 2 diabetes mellitus	0.000173	0.0011	CcSEcCtD
Prochlorperazine—Agitation—Gliclazide—type 2 diabetes mellitus	0.000172	0.00109	CcSEcCtD
Prochlorperazine—Asthma—Ramipril—type 2 diabetes mellitus	0.000171	0.00109	CcSEcCtD
Prochlorperazine—Influenza—Ramipril—type 2 diabetes mellitus	0.000171	0.00109	CcSEcCtD
Prochlorperazine—Dysphagia—Ramipril—type 2 diabetes mellitus	0.000171	0.00109	CcSEcCtD
Prochlorperazine—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000171	0.00109	CcSEcCtD
Prochlorperazine—Oedema—Glyburide—type 2 diabetes mellitus	0.00017	0.00108	CcSEcCtD
Prochlorperazine—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000169	0.00108	CcSEcCtD
Prochlorperazine—Rash—Repaglinide—type 2 diabetes mellitus	0.000168	0.00107	CcSEcCtD
Prochlorperazine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000168	0.00107	CcSEcCtD
Prochlorperazine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000168	0.00107	CcSEcCtD
Prochlorperazine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000168	0.00107	CcSEcCtD
Prochlorperazine—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000167	0.00107	CcSEcCtD
Prochlorperazine—Headache—Repaglinide—type 2 diabetes mellitus	0.000167	0.00106	CcSEcCtD
Prochlorperazine—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000167	0.00106	CcSEcCtD
Prochlorperazine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000167	0.00106	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000166	0.00106	CcSEcCtD
Prochlorperazine—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000166	0.00106	CcSEcCtD
Prochlorperazine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000166	0.00106	CcSEcCtD
Prochlorperazine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000165	0.00105	CcSEcCtD
Prochlorperazine—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000165	0.00105	CcSEcCtD
Prochlorperazine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000164	0.00104	CcSEcCtD
Prochlorperazine—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000163	0.00104	CcSEcCtD
Prochlorperazine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000163	0.00104	CcSEcCtD
Prochlorperazine—Cough—Gliclazide—type 2 diabetes mellitus	0.000163	0.00104	CcSEcCtD
Prochlorperazine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000163	0.00104	CcSEcCtD
Prochlorperazine—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000162	0.00103	CcSEcCtD
Prochlorperazine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000162	0.00103	CcSEcCtD
Prochlorperazine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000162	0.00103	CcSEcCtD
Prochlorperazine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00016	0.00102	CcSEcCtD
Prochlorperazine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000159	0.00101	CcSEcCtD
Prochlorperazine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000159	0.00101	CcSEcCtD
Prochlorperazine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000159	0.00101	CcSEcCtD
Prochlorperazine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000159	0.00101	CcSEcCtD
Prochlorperazine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000158	0.00101	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000157	0.001	CcSEcCtD
Prochlorperazine—Angioedema—Valsartan—type 2 diabetes mellitus	0.000157	0.000999	CcSEcCtD
Prochlorperazine—Erythema—Metformin—type 2 diabetes mellitus	0.000156	0.000996	CcSEcCtD
Prochlorperazine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000156	0.000995	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000156	0.000994	CcSEcCtD
Prochlorperazine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000156	0.000992	CcSEcCtD
Prochlorperazine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000156	0.000991	CcSEcCtD
Prochlorperazine—Weight increased—Ramipril—type 2 diabetes mellitus	0.000155	0.000991	CcSEcCtD
Prochlorperazine—Angioedema—Orlistat—type 2 diabetes mellitus	0.000155	0.000988	CcSEcCtD
Prochlorperazine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000152	0.000967	CcSEcCtD
Prochlorperazine—Infection—Gliclazide—type 2 diabetes mellitus	0.000151	0.000965	CcSEcCtD
Prochlorperazine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000151	0.000965	CcSEcCtD
Prochlorperazine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000151	0.000965	CcSEcCtD
Prochlorperazine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000151	0.000964	CcSEcCtD
Prochlorperazine—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000151	0.000961	CcSEcCtD
Prochlorperazine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.00015	0.000958	CcSEcCtD
Prochlorperazine—Fluphenazine—CALM1—type 2 diabetes mellitus	0.00015	0.0303	CrCbGaD
Prochlorperazine—Cough—Valsartan—type 2 diabetes mellitus	0.00015	0.000954	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000149	0.000951	CcSEcCtD
Prochlorperazine—Jaundice—Ramipril—type 2 diabetes mellitus	0.000148	0.000946	CcSEcCtD
Prochlorperazine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000148	0.000944	CcSEcCtD
Prochlorperazine—Cough—Orlistat—type 2 diabetes mellitus	0.000148	0.000943	CcSEcCtD
Prochlorperazine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000148	0.00094	CcSEcCtD
Prochlorperazine—Erythema—Irbesartan—type 2 diabetes mellitus	0.000147	0.00094	CcSEcCtD
Prochlorperazine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000147	0.000939	CcSEcCtD
Prochlorperazine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000147	0.000936	CcSEcCtD
Prochlorperazine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000147	0.000936	CcSEcCtD
Prochlorperazine—Tremor—Metformin—type 2 diabetes mellitus	0.000146	0.000933	CcSEcCtD
Prochlorperazine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000146	0.00093	CcSEcCtD
Prochlorperazine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000146	0.000928	CcSEcCtD
Prochlorperazine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000143	0.000913	CcSEcCtD
Prochlorperazine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000143	0.000911	CcSEcCtD
Prochlorperazine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000142	0.000908	CcSEcCtD
Prochlorperazine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000142	0.000908	CcSEcCtD
Prochlorperazine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000142	0.000906	CcSEcCtD
Prochlorperazine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000142	0.000904	CcSEcCtD
Prochlorperazine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000141	0.0009	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00014	0.000893	CcSEcCtD
Prochlorperazine—Oedema—Valsartan—type 2 diabetes mellitus	0.00014	0.000893	CcSEcCtD
Prochlorperazine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00014	0.000891	CcSEcCtD
Prochlorperazine—Infection—Valsartan—type 2 diabetes mellitus	0.000139	0.000887	CcSEcCtD
Prochlorperazine—Rash—Glipizide—type 2 diabetes mellitus	0.000139	0.000886	CcSEcCtD
Prochlorperazine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000139	0.000886	CcSEcCtD
Prochlorperazine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000139	0.000886	CcSEcCtD
Prochlorperazine—Erythema—Losartan—type 2 diabetes mellitus	0.000139	0.000885	CcSEcCtD
Prochlorperazine—Oedema—Orlistat—type 2 diabetes mellitus	0.000138	0.000882	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000138	0.000882	CcSEcCtD
Prochlorperazine—Headache—Glipizide—type 2 diabetes mellitus	0.000138	0.000881	CcSEcCtD
Prochlorperazine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000138	0.000881	CcSEcCtD
Prochlorperazine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000138	0.000879	CcSEcCtD
Prochlorperazine—Infection—Orlistat—type 2 diabetes mellitus	0.000137	0.000876	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000137	0.000874	CcSEcCtD
Prochlorperazine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000136	0.000868	CcSEcCtD
Prochlorperazine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000136	0.000867	CcSEcCtD
Prochlorperazine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000136	0.000866	CcSEcCtD
Prochlorperazine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000136	0.000865	CcSEcCtD
Prochlorperazine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000136	0.000864	CcSEcCtD
Prochlorperazine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000136	0.000864	CcSEcCtD
Prochlorperazine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000135	0.00086	CcSEcCtD
Prochlorperazine—Nervousness—Losartan—type 2 diabetes mellitus	0.000135	0.000859	CcSEcCtD
Prochlorperazine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000135	0.000859	CcSEcCtD
Prochlorperazine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000135	0.000858	CcSEcCtD
Prochlorperazine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000134	0.000857	CcSEcCtD
Prochlorperazine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000133	0.00085	CcSEcCtD
Prochlorperazine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000132	0.000844	CcSEcCtD
Prochlorperazine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000132	0.000841	CcSEcCtD
Prochlorperazine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000131	0.000834	CcSEcCtD
Prochlorperazine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000131	0.000834	CcSEcCtD
Prochlorperazine—Constipation—Gliclazide—type 2 diabetes mellitus	0.00013	0.000831	CcSEcCtD
Prochlorperazine—Tremor—Losartan—type 2 diabetes mellitus	0.00013	0.000829	CcSEcCtD
Prochlorperazine—Rash—Glimepiride—type 2 diabetes mellitus	0.00013	0.000827	CcSEcCtD
Prochlorperazine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00013	0.000826	CcSEcCtD
Prochlorperazine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000825	CcSEcCtD
Prochlorperazine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000824	CcSEcCtD
Prochlorperazine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000129	0.000824	CcSEcCtD
Prochlorperazine—Headache—Glimepiride—type 2 diabetes mellitus	0.000129	0.000822	CcSEcCtD
Prochlorperazine—Cough—Irbesartan—type 2 diabetes mellitus	0.000129	0.00082	CcSEcCtD
Prochlorperazine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000819	CcSEcCtD
Prochlorperazine—Meclizine—CYP1A2—type 2 diabetes mellitus	0.000128	0.0257	CrCbGaD
Prochlorperazine—Agitation—Losartan—type 2 diabetes mellitus	0.000128	0.000813	CcSEcCtD
Prochlorperazine—Oedema—Metformin—type 2 diabetes mellitus	0.000128	0.000813	CcSEcCtD
Prochlorperazine—Propericiazine—ADRA2A—type 2 diabetes mellitus	0.000127	0.0257	CrCbGaD
Prochlorperazine—Angioedema—Losartan—type 2 diabetes mellitus	0.000127	0.000808	CcSEcCtD
Prochlorperazine—Infection—Metformin—type 2 diabetes mellitus	0.000127	0.000808	CcSEcCtD
Prochlorperazine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000127	0.000807	CcSEcCtD
Prochlorperazine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000125	0.000798	CcSEcCtD
Prochlorperazine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000125	0.000797	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000125	0.000796	CcSEcCtD
Prochlorperazine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000125	0.000796	CcSEcCtD
Prochlorperazine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000124	0.000794	CcSEcCtD
Prochlorperazine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000124	0.000792	CcSEcCtD
Prochlorperazine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000124	0.00079	CcSEcCtD
Prochlorperazine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000123	0.000783	CcSEcCtD
Prochlorperazine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000123	0.000783	CcSEcCtD
Prochlorperazine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000122	0.000778	CcSEcCtD
Prochlorperazine—Promethazine—CALM1—type 2 diabetes mellitus	0.000122	0.0245	CrCbGaD
Prochlorperazine—Cough—Losartan—type 2 diabetes mellitus	0.000121	0.000772	CcSEcCtD
Prochlorperazine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000121	0.000772	CcSEcCtD
Prochlorperazine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00012	0.000768	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00012	0.000767	CcSEcCtD
Prochlorperazine—Oedema—Irbesartan—type 2 diabetes mellitus	0.00012	0.000767	CcSEcCtD
Prochlorperazine—Pruritus—Glyburide—type 2 diabetes mellitus	0.00012	0.000766	CcSEcCtD
Prochlorperazine—Trifluoperazine—CALM1—type 2 diabetes mellitus	0.00012	0.0242	CrCbGaD
Prochlorperazine—Constipation—Valsartan—type 2 diabetes mellitus	0.00012	0.000763	CcSEcCtD
Prochlorperazine—Infection—Irbesartan—type 2 diabetes mellitus	0.00012	0.000762	CcSEcCtD
Prochlorperazine—Hypotension—Metformin—type 2 diabetes mellitus	0.000119	0.00076	CcSEcCtD
Prochlorperazine—Erythema—Ramipril—type 2 diabetes mellitus	0.000119	0.000758	CcSEcCtD
Prochlorperazine—Perphenazine—CALM1—type 2 diabetes mellitus	0.000119	0.024	CrCbGaD
Prochlorperazine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000118	0.000751	CcSEcCtD
Prochlorperazine—Cyamemazine—HTR2C—type 2 diabetes mellitus	0.000117	0.0236	CrCbGaD
Prochlorperazine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000746	CcSEcCtD
Prochlorperazine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000746	CcSEcCtD
Prochlorperazine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000117	0.000745	CcSEcCtD
Prochlorperazine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000116	0.000741	CcSEcCtD
Prochlorperazine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000116	0.000737	CcSEcCtD
Prochlorperazine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000116	0.000737	CcSEcCtD
Prochlorperazine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000114	0.000729	CcSEcCtD
Prochlorperazine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000114	0.000725	CcSEcCtD
Prochlorperazine—Somnolence—Metformin—type 2 diabetes mellitus	0.000113	0.000723	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000113	0.000722	CcSEcCtD
Prochlorperazine—Oedema—Losartan—type 2 diabetes mellitus	0.000113	0.000722	CcSEcCtD
Prochlorperazine—Infection—Losartan—type 2 diabetes mellitus	0.000113	0.000717	CcSEcCtD
Prochlorperazine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000112	0.000717	CcSEcCtD
Prochlorperazine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000112	0.000716	CcSEcCtD
Prochlorperazine—Tremor—Ramipril—type 2 diabetes mellitus	0.000111	0.000711	CcSEcCtD
Prochlorperazine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000111	0.000709	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000111	0.000707	CcSEcCtD
Prochlorperazine—Urticaria—Orlistat—type 2 diabetes mellitus	0.00011	0.000701	CcSEcCtD
Prochlorperazine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000109	0.000697	CcSEcCtD
Prochlorperazine—Agitation—Ramipril—type 2 diabetes mellitus	0.000109	0.000697	CcSEcCtD
Prochlorperazine—Constipation—Metformin—type 2 diabetes mellitus	0.000109	0.000695	CcSEcCtD
Prochlorperazine—Metixene—HTR2C—type 2 diabetes mellitus	0.000109	0.022	CrCbGaD
Prochlorperazine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000109	0.000693	CcSEcCtD
Prochlorperazine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000108	0.000687	CcSEcCtD
Prochlorperazine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000107	0.000684	CcSEcCtD
Prochlorperazine—Rash—Glyburide—type 2 diabetes mellitus	0.000107	0.000682	CcSEcCtD
Prochlorperazine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000107	0.000682	CcSEcCtD
Prochlorperazine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000107	0.000682	CcSEcCtD
Prochlorperazine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000107	0.000679	CcSEcCtD
Prochlorperazine—Headache—Glyburide—type 2 diabetes mellitus	0.000106	0.000678	CcSEcCtD
Prochlorperazine—Hypotension—Losartan—type 2 diabetes mellitus	0.000106	0.000675	CcSEcCtD
Prochlorperazine—Cough—Ramipril—type 2 diabetes mellitus	0.000104	0.000662	CcSEcCtD
Prochlorperazine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000103	0.000658	CcSEcCtD
Prochlorperazine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000103	0.000657	CcSEcCtD
Prochlorperazine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000103	0.000656	CcSEcCtD
Prochlorperazine—Insomnia—Losartan—type 2 diabetes mellitus	0.000102	0.000653	CcSEcCtD
Prochlorperazine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000102	0.00065	CcSEcCtD
Prochlorperazine—Urticaria—Metformin—type 2 diabetes mellitus	0.000101	0.000646	CcSEcCtD
Prochlorperazine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000101	0.000644	CcSEcCtD
Prochlorperazine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000101	0.000642	CcSEcCtD
Prochlorperazine—Somnolence—Losartan—type 2 diabetes mellitus	0.000101	0.000642	CcSEcCtD
Prochlorperazine—Pruritus—Valsartan—type 2 diabetes mellitus	9.91e-05	0.000632	CcSEcCtD
Prochlorperazine—Dry mouth—Ramipril—type 2 diabetes mellitus	9.91e-05	0.000632	CcSEcCtD
Prochlorperazine—Pruritus—Orlistat—type 2 diabetes mellitus	9.79e-05	0.000624	CcSEcCtD
Prochlorperazine—Oedema—Ramipril—type 2 diabetes mellitus	9.71e-05	0.000619	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.71e-05	0.000619	CcSEcCtD
Prochlorperazine—Constipation—Losartan—type 2 diabetes mellitus	9.69e-05	0.000617	CcSEcCtD
Prochlorperazine—Rash—Gliclazide—type 2 diabetes mellitus	9.61e-05	0.000613	CcSEcCtD
Prochlorperazine—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.6e-05	0.000612	CcSEcCtD
Prochlorperazine—Urticaria—Irbesartan—type 2 diabetes mellitus	9.56e-05	0.000609	CcSEcCtD
Prochlorperazine—Headache—Gliclazide—type 2 diabetes mellitus	9.55e-05	0.000609	CcSEcCtD
Prochlorperazine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.000606	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.51e-05	0.000606	CcSEcCtD
Prochlorperazine—Skin disorder—Ramipril—type 2 diabetes mellitus	9.43e-05	0.000601	CcSEcCtD
Prochlorperazine—Chlorpromazine—CALM1—type 2 diabetes mellitus	9.42e-05	0.019	CrCbGaD
Prochlorperazine—Dizziness—Valsartan—type 2 diabetes mellitus	9.26e-05	0.00059	CcSEcCtD
Prochlorperazine—Dizziness—Orlistat—type 2 diabetes mellitus	9.15e-05	0.000583	CcSEcCtD
Prochlorperazine—Zuclopenthixol—ADRA2A—type 2 diabetes mellitus	9.12e-05	0.0184	CrCbGaD
Prochlorperazine—Hypotension—Ramipril—type 2 diabetes mellitus	9.07e-05	0.000578	CcSEcCtD
Prochlorperazine—Nefazodone—ADRA2A—type 2 diabetes mellitus	9.07e-05	0.0183	CrCbGaD
Prochlorperazine—Pruritus—Metformin—type 2 diabetes mellitus	9.02e-05	0.000575	CcSEcCtD
Prochlorperazine—Urticaria—Losartan—type 2 diabetes mellitus	9e-05	0.000574	CcSEcCtD
Prochlorperazine—Body temperature increased—Losartan—type 2 diabetes mellitus	8.95e-05	0.000571	CcSEcCtD
Prochlorperazine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.87e-05	0.000565	CcSEcCtD
Prochlorperazine—Rash—Valsartan—type 2 diabetes mellitus	8.83e-05	0.000563	CcSEcCtD
Prochlorperazine—Dermatitis—Valsartan—type 2 diabetes mellitus	8.82e-05	0.000562	CcSEcCtD
Prochlorperazine—Insomnia—Ramipril—type 2 diabetes mellitus	8.78e-05	0.00056	CcSEcCtD
Prochlorperazine—Headache—Valsartan—type 2 diabetes mellitus	8.77e-05	0.000559	CcSEcCtD
Prochlorperazine—Rash—Orlistat—type 2 diabetes mellitus	8.72e-05	0.000556	CcSEcCtD
Prochlorperazine—Dermatitis—Orlistat—type 2 diabetes mellitus	8.72e-05	0.000556	CcSEcCtD
Prochlorperazine—Headache—Orlistat—type 2 diabetes mellitus	8.67e-05	0.000553	CcSEcCtD
Prochlorperazine—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.66e-05	0.000552	CcSEcCtD
Prochlorperazine—Somnolence—Ramipril—type 2 diabetes mellitus	8.63e-05	0.00055	CcSEcCtD
Prochlorperazine—Pruritus—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.000543	CcSEcCtD
Prochlorperazine—Dizziness—Metformin—type 2 diabetes mellitus	8.43e-05	0.000538	CcSEcCtD
Prochlorperazine—Aripiprazole—ADRA2A—type 2 diabetes mellitus	8.43e-05	0.017	CrCbGaD
Prochlorperazine—Trazodone—ADRA2A—type 2 diabetes mellitus	8.39e-05	0.0169	CrCbGaD
Prochlorperazine—Nefazodone—HTR2C—type 2 diabetes mellitus	8.35e-05	0.0168	CrCbGaD
Prochlorperazine—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.34e-05	0.000532	CcSEcCtD
Prochlorperazine—Constipation—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000529	CcSEcCtD
Prochlorperazine—Rash—Metformin—type 2 diabetes mellitus	8.04e-05	0.000513	CcSEcCtD
Prochlorperazine—Dermatitis—Metformin—type 2 diabetes mellitus	8.03e-05	0.000512	CcSEcCtD
Prochlorperazine—Pruritus—Losartan—type 2 diabetes mellitus	8.01e-05	0.000511	CcSEcCtD
Prochlorperazine—Headache—Metformin—type 2 diabetes mellitus	7.99e-05	0.000509	CcSEcCtD
Prochlorperazine—Dizziness—Irbesartan—type 2 diabetes mellitus	7.96e-05	0.000507	CcSEcCtD
Prochlorperazine—Thiothixene—ADRA2A—type 2 diabetes mellitus	7.86e-05	0.0159	CrCbGaD
Prochlorperazine—Aripiprazole—HTR2C—type 2 diabetes mellitus	7.76e-05	0.0157	CrCbGaD
Prochlorperazine—Trazodone—HTR2C—type 2 diabetes mellitus	7.73e-05	0.0156	CrCbGaD
Prochlorperazine—Urticaria—Ramipril—type 2 diabetes mellitus	7.72e-05	0.000492	CcSEcCtD
Prochlorperazine—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.68e-05	0.000489	CcSEcCtD
Prochlorperazine—Rash—Irbesartan—type 2 diabetes mellitus	7.59e-05	0.000484	CcSEcCtD
Prochlorperazine—Domperidone—CYP1A2—type 2 diabetes mellitus	7.59e-05	0.0153	CrCbGaD
Prochlorperazine—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.58e-05	0.000483	CcSEcCtD
Prochlorperazine—Headache—Irbesartan—type 2 diabetes mellitus	7.54e-05	0.000481	CcSEcCtD
Prochlorperazine—Dizziness—Losartan—type 2 diabetes mellitus	7.49e-05	0.000477	CcSEcCtD
Prochlorperazine—Thiothixene—HTR2C—type 2 diabetes mellitus	7.24e-05	0.0146	CrCbGaD
Prochlorperazine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.16e-05	0.000456	CcSEcCtD
Prochlorperazine—Mesoridazine—HTR2C—type 2 diabetes mellitus	7.14e-05	0.0144	CrCbGaD
Prochlorperazine—Rash—Losartan—type 2 diabetes mellitus	7.14e-05	0.000455	CcSEcCtD
Prochlorperazine—Dermatitis—Losartan—type 2 diabetes mellitus	7.13e-05	0.000455	CcSEcCtD
Prochlorperazine—Headache—Losartan—type 2 diabetes mellitus	7.1e-05	0.000452	CcSEcCtD
Prochlorperazine—Pruritus—Ramipril—type 2 diabetes mellitus	6.87e-05	0.000438	CcSEcCtD
Prochlorperazine—Mianserin—ADRA2A—type 2 diabetes mellitus	6.8e-05	0.0137	CrCbGaD
Prochlorperazine—Fluphenazine—ADRA2A—type 2 diabetes mellitus	6.8e-05	0.0137	CrCbGaD
Prochlorperazine—Dizziness—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000409	CcSEcCtD
Prochlorperazine—Fluphenazine—HTR2C—type 2 diabetes mellitus	6.26e-05	0.0126	CrCbGaD
Prochlorperazine—Mianserin—HTR2C—type 2 diabetes mellitus	6.26e-05	0.0126	CrCbGaD
Prochlorperazine—Clomipramine—ADRA2A—type 2 diabetes mellitus	6.22e-05	0.0125	CrCbGaD
Prochlorperazine—Rash—Ramipril—type 2 diabetes mellitus	6.12e-05	0.00039	CcSEcCtD
Prochlorperazine—Dermatitis—Ramipril—type 2 diabetes mellitus	6.12e-05	0.00039	CcSEcCtD
Prochlorperazine—Headache—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000388	CcSEcCtD
Prochlorperazine—Propiomazine—HTR2C—type 2 diabetes mellitus	6.02e-05	0.0121	CrCbGaD
Prochlorperazine—Alimemazine—CYP3A4—type 2 diabetes mellitus	5.91e-05	0.0119	CrCbGaD
Prochlorperazine—Thioridazine—ADRA2A—type 2 diabetes mellitus	5.86e-05	0.0118	CrCbGaD
Prochlorperazine—Clomipramine—HTR2C—type 2 diabetes mellitus	5.72e-05	0.0115	CrCbGaD
Prochlorperazine—Chlorprothixene—HTR2C—type 2 diabetes mellitus	5.7e-05	0.0115	CrCbGaD
Prochlorperazine—Methotrimeprazine—ADRA2A—type 2 diabetes mellitus	5.59e-05	0.0113	CrCbGaD
Prochlorperazine—Pipotiazine—CYP1A2—type 2 diabetes mellitus	5.46e-05	0.011	CrCbGaD
Prochlorperazine—Thiothixene—CYP1A2—type 2 diabetes mellitus	5.46e-05	0.011	CrCbGaD
Prochlorperazine—Loxapine—ADRA2A—type 2 diabetes mellitus	5.4e-05	0.0109	CrCbGaD
Prochlorperazine—Thioridazine—HTR2C—type 2 diabetes mellitus	5.39e-05	0.0109	CrCbGaD
Prochlorperazine—Perphenazine—ADRA2A—type 2 diabetes mellitus	5.37e-05	0.0108	CrCbGaD
Prochlorperazine—Quetiapine—ADRA2A—type 2 diabetes mellitus	5.27e-05	0.0106	CrCbGaD
Prochlorperazine—Methotrimeprazine—HTR2C—type 2 diabetes mellitus	5.15e-05	0.0104	CrCbGaD
Prochlorperazine—Mequitazine—CYP3A4—type 2 diabetes mellitus	5.08e-05	0.0103	CrCbGaD
Prochlorperazine—Domperidone—CYP3A4—type 2 diabetes mellitus	5.02e-05	0.0101	CrCbGaD
Prochlorperazine—Trifluoperazine—HTR2C—type 2 diabetes mellitus	5e-05	0.0101	CrCbGaD
Prochlorperazine—Loxapine—HTR2C—type 2 diabetes mellitus	4.97e-05	0.01	CrCbGaD
Prochlorperazine—Fluphenazine—CYP2E1—type 2 diabetes mellitus	4.96e-05	0.01	CrCbGaD
Prochlorperazine—Perphenazine—HTR2C—type 2 diabetes mellitus	4.95e-05	0.00998	CrCbGaD
Prochlorperazine—Quetiapine—HTR2C—type 2 diabetes mellitus	4.85e-05	0.00979	CrCbGaD
Prochlorperazine—Promazine—ADRA2A—type 2 diabetes mellitus	4.84e-05	0.00977	CrCbGaD
Prochlorperazine—Fluphenazine—CYP1A2—type 2 diabetes mellitus	4.72e-05	0.00952	CrCbGaD
Prochlorperazine—Mianserin—CYP1A2—type 2 diabetes mellitus	4.72e-05	0.00952	CrCbGaD
Prochlorperazine—Desipramine—HTR2C—type 2 diabetes mellitus	4.6e-05	0.00929	CrCbGaD
Prochlorperazine—Clozapine—ADRA2A—type 2 diabetes mellitus	4.53e-05	0.00915	CrCbGaD
Prochlorperazine—Promazine—HTR2C—type 2 diabetes mellitus	4.46e-05	0.009	CrCbGaD
Prochlorperazine—Clomipramine—CYP1A2—type 2 diabetes mellitus	4.32e-05	0.00871	CrCbGaD
Prochlorperazine—Thioridazine—CYP2E1—type 2 diabetes mellitus	4.28e-05	0.00863	CrCbGaD
Prochlorperazine—Chlorpromazine—ADRA2A—type 2 diabetes mellitus	4.26e-05	0.0086	CrCbGaD
Prochlorperazine—Clozapine—HTR2C—type 2 diabetes mellitus	4.17e-05	0.00842	CrCbGaD
Prochlorperazine—Nefazodone—CYP3A4—type 2 diabetes mellitus	4.17e-05	0.00841	CrCbGaD
Prochlorperazine—Methotrimeprazine—CYP2E1—type 2 diabetes mellitus	4.08e-05	0.00824	CrCbGaD
Prochlorperazine—Thioridazine—CYP1A2—type 2 diabetes mellitus	4.07e-05	0.00821	CrCbGaD
Prochlorperazine—Chlorpromazine—HTR2C—type 2 diabetes mellitus	3.92e-05	0.00792	CrCbGaD
Prochlorperazine—Imipramine—HTR2C—type 2 diabetes mellitus	3.9e-05	0.00788	CrCbGaD
Prochlorperazine—Methotrimeprazine—CYP1A2—type 2 diabetes mellitus	3.88e-05	0.00783	CrCbGaD
Prochlorperazine—Aripiprazole—CYP3A4—type 2 diabetes mellitus	3.88e-05	0.00782	CrCbGaD
Prochlorperazine—Trazodone—CYP3A4—type 2 diabetes mellitus	3.86e-05	0.00779	CrCbGaD
Prochlorperazine—Trifluoperazine—CYP1A2—type 2 diabetes mellitus	3.77e-05	0.00761	CrCbGaD
Prochlorperazine—Perphenazine—CYP1A2—type 2 diabetes mellitus	3.73e-05	0.00753	CrCbGaD
Prochlorperazine—Desipramine—CYP2E1—type 2 diabetes mellitus	3.65e-05	0.00737	CrCbGaD
Prochlorperazine—Pipotiazine—CYP3A4—type 2 diabetes mellitus	3.62e-05	0.0073	CrCbGaD
Prochlorperazine—Clobazam—CYP3A4—type 2 diabetes mellitus	3.62e-05	0.0073	CrCbGaD
Prochlorperazine—Desipramine—CYP1A2—type 2 diabetes mellitus	3.47e-05	0.00701	CrCbGaD
Prochlorperazine—Promazine—CYP1A2—type 2 diabetes mellitus	3.37e-05	0.00679	CrCbGaD
Prochlorperazine—Clozapine—CYP2E1—type 2 diabetes mellitus	3.31e-05	0.00668	CrCbGaD
Prochlorperazine—Acepromazine—ALB—type 2 diabetes mellitus	3.28e-05	0.00662	CrCbGaD
Prochlorperazine—Thioproperazine—ALB—type 2 diabetes mellitus	3.21e-05	0.00647	CrCbGaD
Prochlorperazine—Thiothixene—ALB—type 2 diabetes mellitus	3.15e-05	0.00636	CrCbGaD
Prochlorperazine—Pipotiazine—ALB—type 2 diabetes mellitus	3.15e-05	0.00636	CrCbGaD
Prochlorperazine—Clozapine—CYP1A2—type 2 diabetes mellitus	3.15e-05	0.00635	CrCbGaD
Prochlorperazine—Mianserin—CYP3A4—type 2 diabetes mellitus	3.13e-05	0.00631	CrCbGaD
Prochlorperazine—Chlorpromazine—CYP2E1—type 2 diabetes mellitus	3.11e-05	0.00628	CrCbGaD
Prochlorperazine—Imipramine—CYP2E1—type 2 diabetes mellitus	3.1e-05	0.00625	CrCbGaD
Prochlorperazine—Chlorpromazine—CYP1A2—type 2 diabetes mellitus	2.96e-05	0.00597	CrCbGaD
Prochlorperazine—Imipramine—CYP1A2—type 2 diabetes mellitus	2.95e-05	0.00594	CrCbGaD
Prochlorperazine—Clomipramine—CYP3A4—type 2 diabetes mellitus	2.86e-05	0.00577	CrCbGaD
Prochlorperazine—Clomipramine—ALB—type 2 diabetes mellitus	2.49e-05	0.00503	CrCbGaD
Prochlorperazine—Perphenazine—CYP3A4—type 2 diabetes mellitus	2.47e-05	0.00499	CrCbGaD
Prochlorperazine—Quetiapine—CYP3A4—type 2 diabetes mellitus	2.42e-05	0.00489	CrCbGaD
Prochlorperazine—Desipramine—CYP3A4—type 2 diabetes mellitus	2.3e-05	0.00464	CrCbGaD
Prochlorperazine—Promazine—CYP3A4—type 2 diabetes mellitus	2.23e-05	0.00449	CrCbGaD
Prochlorperazine—Clozapine—CYP3A4—type 2 diabetes mellitus	2.08e-05	0.00421	CrCbGaD
Prochlorperazine—Chlorpromazine—CYP3A4—type 2 diabetes mellitus	1.96e-05	0.00396	CrCbGaD
Prochlorperazine—Imipramine—CYP3A4—type 2 diabetes mellitus	1.95e-05	0.00394	CrCbGaD
Prochlorperazine—Chlorpromazine—ALB—type 2 diabetes mellitus	1.71e-05	0.00345	CrCbGaD
Prochlorperazine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	6.58e-06	0.000113	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	6.58e-06	0.000113	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.57e-06	0.000113	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—C3—type 2 diabetes mellitus	6.54e-06	0.000112	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.49e-06	0.000111	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	6.49e-06	0.000111	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.46e-06	0.000111	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	6.46e-06	0.000111	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—LPL—type 2 diabetes mellitus	6.42e-06	0.00011	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	6.4e-06	0.00011	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.39e-06	0.000109	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	6.3e-06	0.000108	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.28e-06	0.000108	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.27e-06	0.000107	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	6.26e-06	0.000107	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	6.25e-06	0.000107	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.24e-06	0.000107	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.23e-06	0.000107	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AGT—type 2 diabetes mellitus	6.22e-06	0.000107	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	6.2e-06	0.000106	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.17e-06	0.000106	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.11e-06	0.000105	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—LEP—type 2 diabetes mellitus	6.09e-06	0.000104	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—APOE—type 2 diabetes mellitus	6.09e-06	0.000104	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.07e-06	0.000104	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.04e-06	0.000103	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.04e-06	0.000103	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.04e-06	0.000103	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.04e-06	0.000103	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.02e-06	0.000103	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.02e-06	0.000103	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	6.02e-06	0.000103	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—INS—type 2 diabetes mellitus	6e-06	0.000103	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.95e-06	0.000102	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.95e-06	0.000102	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.91e-06	0.000101	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.91e-06	0.000101	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.91e-06	0.000101	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.81e-06	9.96e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.81e-06	9.95e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.8e-06	9.94e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.8e-06	9.94e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.8e-06	9.94e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.79e-06	9.91e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.78e-06	9.9e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	5.78e-06	9.89e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.75e-06	9.84e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.71e-06	9.78e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.7e-06	9.77e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.7e-06	9.77e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	5.67e-06	9.71e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	5.58e-06	9.56e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.51e-06	9.45e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.51e-06	9.44e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.49e-06	9.41e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	5.49e-06	9.4e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.44e-06	9.31e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.41e-06	9.26e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.4e-06	9.24e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.39e-06	9.24e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	5.39e-06	9.23e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.38e-06	9.21e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	5.38e-06	9.21e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	5.38e-06	9.21e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.32e-06	9.12e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.32e-06	9.11e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.31e-06	9.09e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	5.3e-06	9.08e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.3e-06	9.08e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.28e-06	9.04e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.28e-06	9.04e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.26e-06	9.02e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.26e-06	9.02e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.22e-06	8.94e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.21e-06	8.93e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—INS—type 2 diabetes mellitus	5.21e-06	8.92e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	5.19e-06	8.9e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	5.19e-06	8.9e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.14e-06	8.8e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.12e-06	8.77e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.07e-06	8.69e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.03e-06	8.62e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.03e-06	8.62e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.02e-06	8.6e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.01e-06	8.58e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.98e-06	8.53e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—RELA—type 2 diabetes mellitus	4.96e-06	8.49e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.92e-06	8.43e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.92e-06	8.43e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.92e-06	8.42e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.92e-06	8.42e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.9e-06	8.39e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.89e-06	8.38e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.83e-06	8.27e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.82e-06	8.27e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.8e-06	8.22e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.79e-06	8.21e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.79e-06	8.21e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.79e-06	8.21e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.78e-06	8.19e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.77e-06	8.16e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.71e-06	8.07e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.69e-06	8.03e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.68e-06	8.02e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.63e-06	7.94e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.63e-06	7.92e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	4.59e-06	7.87e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.56e-06	7.82e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.56e-06	7.82e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.56e-06	7.81e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.52e-06	7.74e-05	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.51e-06	7.73e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	4.51e-06	7.73e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.48e-06	7.67e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.47e-06	7.66e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.44e-06	7.61e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.44e-06	7.61e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.44e-06	7.61e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	4.44e-06	7.6e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.44e-06	7.6e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.42e-06	7.57e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	4.38e-06	7.5e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.37e-06	7.48e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	4.37e-06	7.48e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.36e-06	7.47e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.36e-06	7.47e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.34e-06	7.44e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.3e-06	7.37e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.3e-06	7.37e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.3e-06	7.37e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	4.3e-06	7.36e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.29e-06	7.35e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.29e-06	7.35e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.27e-06	7.32e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	4.25e-06	7.28e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.22e-06	7.24e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.22e-06	7.23e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.22e-06	7.23e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.2e-06	7.19e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.18e-06	7.17e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.18e-06	7.16e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.14e-06	7.1e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.1e-06	7.02e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.09e-06	7.01e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.08e-06	6.98e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	4.03e-06	6.9e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.03e-06	6.9e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.03e-06	6.9e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.96e-06	6.78e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.96e-06	6.78e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.95e-06	6.77e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.93e-06	6.74e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.91e-06	6.7e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	3.89e-06	6.67e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.89e-06	6.67e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.89e-06	6.67e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.89e-06	6.66e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.89e-06	6.66e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.88e-06	6.64e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.85e-06	6.6e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.83e-06	6.56e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.79e-06	6.5e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.79e-06	6.5e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.76e-06	6.45e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.75e-06	6.43e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.73e-06	6.39e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.73e-06	6.39e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.72e-06	6.38e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.71e-06	6.35e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.66e-06	6.28e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.66e-06	6.27e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.62e-06	6.21e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.55e-06	6.08e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.48e-06	5.96e-05	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.45e-06	5.91e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.42e-06	5.86e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.41e-06	5.85e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.4e-06	5.82e-05	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.39e-06	5.81e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	3.38e-06	5.78e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.36e-06	5.75e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.34e-06	5.72e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.33e-06	5.71e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.3e-06	5.66e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.29e-06	5.63e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.28e-06	5.62e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.27e-06	5.6e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.23e-06	5.54e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.21e-06	5.51e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.21e-06	5.51e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.2e-06	5.49e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.2e-06	5.48e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.2e-06	5.48e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.17e-06	5.44e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.16e-06	5.41e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.14e-06	5.38e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.13e-06	5.37e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.12e-06	5.35e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.09e-06	5.29e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.08e-06	5.27e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.06e-06	5.25e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.03e-06	5.19e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.02e-06	5.17e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.98e-06	5.11e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.98e-06	5.1e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.96e-06	5.07e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.94e-06	5.03e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.93e-06	5.01e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.93e-06	5.01e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.9e-06	4.97e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.88e-06	4.93e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.86e-06	4.91e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.85e-06	4.89e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.85e-06	4.88e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.81e-06	4.81e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.81e-06	4.81e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.8e-06	4.8e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.78e-06	4.76e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.75e-06	4.7e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.66e-06	4.56e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.63e-06	4.51e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.62e-06	4.49e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.62e-06	4.48e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.61e-06	4.47e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.58e-06	4.43e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.57e-06	4.41e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.57e-06	4.4e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.56e-06	4.39e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.52e-06	4.32e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.5e-06	4.29e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.46e-06	4.22e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.45e-06	4.2e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.42e-06	4.15e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.42e-06	4.15e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	2.27e-06	3.9e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.14e-06	3.66e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.1e-06	3.59e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.1e-06	3.59e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.01e-06	3.44e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.97e-06	3.38e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.94e-06	3.32e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.92e-06	3.29e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.85e-06	3.17e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.84e-06	3.15e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.84e-06	3.15e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.82e-06	3.11e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.79e-06	3.06e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.68e-06	2.88e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.29e-06	2.21e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	8.45e-07	1.45e-05	CbGpPWpGaD
